BBI (Europe) Ltd (Bruin Biometrics ) modifies care pathways of chronic, preventable conditions through developing and collaboratively integrating new-to-the-world biometric-sensor based medical devices and point-of-care diagnostic solutions for early detection and monitoring. The company’s lead product is the SEM Scanner, a hand-held non-invasive device that assesses sub-epidermal moisture, an early indicator for pressure damage (bed sores/pressure ulceration/injury, deep tissue injury). SEM Scanner is CE Mark and Health Canada approved and has been granted U.S. Food and Drug Administration (FDA) marketing authorisation.

See for more information.